Is there a role for prostate cancer lesion boost with EBRT in the setting of combination EBRT+ brachytherapy?

I’m not sure if I see a significant rationale for employing an EBRT focal boost in addition to a whole-gland brachytherapy boost. If one were to want to deliver more dose with this treatment paradigm, it seems more dosimetrically efficient to boost the area with brachytherapy. Prior work has also re...